BioGaia AB/Skr BIOG B
07:00
08:00
09:00
10:00
11:00
1D1W1MYTD1Y5YMAX
About BioGaia AB
BioGaia AB is a Swedish biotechnology company that specializes in the development and commercialization of probiotic products. The company's core business revolves around creating proprietary probiotic strains that are used to support digestive health. Notably, BioGaia's products are often formulated into dietary supplements, as well as being incorporated into infant formula and dairy products. Founded in 1990, BioGaia is headquartered in Stockholm, Sweden, and operates on a global scale, distributing its products in over 100 countries. The company is strategically positioned through its research collaborations and partnerships, enhancing its competitive strengths in the probiotic segment.
Ticker
Skr BIOG B
Sector
Primary listing
XSTO
Employees
242
Headquarters
Stockholm, Sweden
Website
BioGaia AB Metrics
BasicAdvanced
kr 12bn
35.93
kr 3.29
0.32
kr 6.90
1.65%
Price and volume
Market cap
kr 12bn
Beta
0.32
52-week high
kr 124.00
52-week low
kr 93.20
Average daily volume
175k
Dividend rate
kr 6.90
Financial strength
Current ratio
6.122
Quick ratio
5.211
Long term debt to equity
1.237
Total debt to equity
1.762
Dividend payout ratio (TTM)
59.28%
Interest coverage (TTM)
74.62%
Profitability
EBITDA (TTM)
468.915
Gross margin (TTM)
73.37%
Net profit margin (TTM)
21.63%
Operating margin (TTM)
29.38%
Effective tax rate (TTM)
21.00%
Revenue per employee (TTM)
kr 6,360,000
Management effectiveness
Return on assets (TTM)
15.56%
Return on equity (TTM)
21.91%
Valuation
Price to earnings (TTM)
35.933
Price to revenue (TTM)
7.774
Price to book
9.14
Price to tangible book (TTM)
10.29
Price to free cash flow (TTM)
39.468
Free cash flow yield (TTM)
2.53%
Free cash flow per share (TTM)
2.995
Dividend yield (TTM)
5.84%
Forward dividend yield
1.65%
Growth
Revenue change (TTM)
8.11%
Earnings per share change (TTM)
-5.38%
3-year revenue growth (CAGR)
11.69%
10-year revenue growth (CAGR)
12.28%
3-year earnings per share growth (CAGR)
-3.84%
10-year earnings per share growth (CAGR)
8.90%
3-year dividend per share growth (CAGR)
4.19%
10-year dividend per share growth (CAGR)
10.47%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
FAQs
What’s the current market cap for BioGaia AB stock?
BioGaia AB (BIOG B) has a market cap of Skr12B as of May 01, 2026.
What is the P/E ratio for BioGaia AB stock?
The price to earnings (P/E) ratio for BioGaia AB (BIOG B) stock is 35.93 as of May 01, 2026.
Does BioGaia AB stock pay dividends?
Yes, the BioGaia AB (BIOG B) stock pays dividends to shareholders. As of May 01, 2026, the dividend rate is Skr6.9 and the yield is 1.65%. BioGaia AB has a payout ratio of 59.28% on a trailing twelve-month basis.
When is the next BioGaia AB dividend payment date?
The next BioGaia AB (BIOG B) dividend payment date is unconfirmed.
What is the beta indicator for BioGaia AB?
BioGaia AB (BIOG B) has a beta rating of 0.32. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.